ClinicalTrials.Veeva

Menu

The Clinical and Prognostic Features of PRES

D

Dunjin Chen

Status

Completed

Conditions

Preeclampsia
Posterior Reversible Encephalopathy Syndrome
Pregnancy Outcomes
Eclampsia

Treatments

Diagnostic Test: PRES in PE or E

Study type

Observational

Funder types

Other

Identifiers

NCT05143710
2020M682675

Details and patient eligibility

About

The purpose of this study is to determine the features of clinical imaging, disease severity and pregnancy outcomes in posterior reversible encephalopathy syndrome with preeclampsia or eclampsia.

Full description

The investigators retrospectively collected data (General information, clinical data, biochemical indicators, imaging features, and pregnancy outcome) from pregnant woman diagnosed with PRES with preeclampsia or eclampsia to analyze features of clinical imaging, disease severity and pregnancy outcomes during 2012 to 2021.Then, the investigators grouped all the patients into early onset group and late onset PE group according to gestational weeks to analyze differences of clinical imaging. Finally, the investigators grouped all the patients into good pregnancy outcomes group and poor pregnancy outcomes group according to diagnostic criteria, including the incidence of stillbirth and premature birth, to analyze differences of clinical imaging .

Enrollment

354 patients

Sex

Female

Ages

16 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. patients were diagnosed of PRES with PE or E
  2. all patients provided written informed consent

Exclusion criteria

  1. patients combined with other neurological disorders
  2. patients combined with mental illness

Trial design

354 participants in 1 patient group

PRES in PE or E
Description:
patients diagnosed with PRES in PE or E
Treatment:
Diagnostic Test: PRES in PE or E

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems